Gilead Sciences, Inc. (GILD) operating KPIs
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)
Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%
Gilead Sciences total debt carrying value ($M) ($M)
Form 10-Q / 10-K Note 10 Debt and Credit Facilities
Latest, Q2 2026
26,246
Period ended Jun 30, 2026
Change on a year earlier
+5.2%
24,946 in Q2 2025
History
32 quarters
Since Q1 2014
Sources
29
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total debt carrying value ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 26,246 | +5.2% | Form 10-Q (filed 2026-08-06) ↗ |
| Q1 2026 | Mar 31, 2026 | 22,174 | -11.1% | Form 10-Q (filed 2026-05-07) ↗ |
| Q4 2025 | Dec 31, 2025 | 24,937 | -6.6% | Form 10-Q (filed 2026-08-06) ↗ |
| Q3 2025 | Sep 30, 2025 | 24,941 | +7.3% | Form 10-Q (filed 2025-11-07) ↗ |
| Q2 2025 | Jun 30, 2025 | 24,946 | +6.8% | Form 10-Q (filed 2025-08-07) ↗ |
| Q1 2025 | Mar 31, 2025 | 24,952 | -1.0% | Form 10-Q (filed 2025-05-07) ↗ |
| Q4 2024 | Dec 31, 2024 | 26,710 | +6.9% | Form 10-K (filed 2026-02-24) ↗ |
| Q3 2024 | Sep 30, 2024 | 23,249 | -6.9% | Form 10-Q (filed 2024-11-12) ↗ |
| Q2 2024 | Jun 30, 2024 | 23,349 | -7.5% | Form 10-Q (filed 2024-08-08) ↗ |
| Q1 2024 | Mar 31, 2024 | 25,193 | -0.2% | Form 10-Q (filed 2024-05-08) ↗ |
| Q4 2023 | Dec 31, 2023 | 24,987 | -1.0% | Form 10-K (filed 2025-02-28) ↗ |
| Q3 2023 | Sep 30, 2023 | 24,982 | -1.0% | Form 10-Q (filed 2023-11-07) ↗ |
| Q2 2023 | Jun 30, 2023 | 25,246 | -3.7% | Form 10-Q (filed 2023-08-04) ↗ |
| Q1 2023 | Mar 31, 2023 | 25,238 | -3.7% | Form 10-Q (filed 2023-05-03) ↗ |
| Q4 2022 | Dec 31, 2022 | 25,229 | -5.5% | Form 10-K (filed 2024-02-23) ↗ |
| Q3 2022 | Sep 30, 2022 | 25,223 | -8.9% | Form 10-Q (filed 2022-11-02) ↗ |
| Q2 2022 | Jun 30, 2022 | 26,216 | -13.1% | Form 10-Q (filed 2022-08-08) ↗ |
| Q1 2022 | Mar 31, 2022 | 26,208 | -13.1% | Form 10-Q (filed 2022-05-04) ↗ |
| Q4 2021 | Dec 31, 2021 | 26,695 | -15.0% | Form 10-K (filed 2023-02-22) ↗ |
| Q3 2021 | Sep 30, 2021 | 27,686 | – | Form 10-Q (filed 2021-11-03) ↗ |
| Q2 2021 | Jun 30, 2021 | 30,175 | – | Form 10-Q (filed 2021-08-05) ↗ |
| Q1 2021 | Mar 31, 2021 | 30,166 | – | Form 10-Q (filed 2021-05-06) ↗ |
| Q4 2020 | Dec 31, 2020 | 31,402 | – | Form 10-K (filed 2022-02-23) ↗ |
| Q3 2018 | Sep 30, 2018 | 27,316 | – | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2018 | Jun 30, 2018 | 29,060 | – | Form 10-Q (filed 2018-08-06) ↗ |
| Q4 2017 | Dec 31, 2017 | 33,542 | – | Form 10-Q (filed 2018-11-06) ↗ |
| Q4 2015 | Dec 31, 2015 | 22,178 | +78.8% | Form 10-K (filed 2016-02-24) ↗ |
| Q1 2015 | Mar 31, 2015 | 12,363 | +26.1% | Form 10-Q (filed 2015-05-08) ↗ |
| Q4 2014 | Dec 31, 2014 | 12,404 | – | Form 10-K (filed 2016-02-24) ↗ |
| Q3 2014 | Sep 30, 2014 | 9,410 | – | SEC Filing ↗ |
| Q2 2014 | Jun 30, 2014 | 9,505 | – | SEC Filing ↗ |
| Q1 2014 | Mar 31, 2014 | 9,804 | – | SEC Filing ↗ |
Cite this data
StockData. (2026). Gilead Sciences Total debt carrying value ($M) ($M), quarterly Q1 2014–Q2 2026 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/debt_tot_carrying
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.